Drug Database · Clinicians

Eribulin

Brands (2) Ebunat, HalavenShow all

Antineoplastic agent PH FDA category

Rx · Prescription drug2 PH productsVAT-exempt
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6, version date January 26, 2026 (Halaven · BSP Pharmaceuticals SpA). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • ) solution for injection: 500 mcg/mL (1 mg/2 mL

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Eribulin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Eribulin
Package insert
EbunatEribulin Mesylate
500 mcg/mL (1 mg/2 mL) Solution for Injection (I.V.)5mL Vial with Ammonium Sulphate treated with rubber stopper and dark blue flip-off seal (Box of 1's)
RxVAT-exempt
Natco Pharma Limited Pharma Division (Unit IV, V and XII)India
Natco Lifesciences Philippines Inc.
DRP-17197
Oct 17, 2030
HalavenEribulin mesilate
500 mcg/mL (1mg/2mL) Solution for Injection (IV)5 mL-capacity USP Type 1 Clear Glass vial x 2 mL (net content) with gray butyl rubber stopper and blue colored aluminum flip-off seal (Box of 1's)
RxVAT-exempt
BSP Pharmaceuticals S.p.A.Italy
Zuellig Pharma CorporationImporter: Hi-Eisai Pharmaceutical, Inc.
DR-XY45789
Feb 22, 2032

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Halaven · BSP Pharmaceuticals SpA [US FDA-approved label, version 58, January 26, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .